EVOLVE2CARE will reveal inhibitors to HealthTech innovation in the Transitional Care sector
EVOLVE2CARE aims to create an ecosystem that fosters experimentation, leading to valuable insights, novel ideas and advancements for innovators, researchers, regulators, and other HealthTech stakeholders. By developing a framework that affords a common approach for practices, EVOLVE2CARE will provide Living Labs with a market-centric paradigm and tool that can expand their impact as experimentation spaces, breaking down the silos which can occur in small local or regional networks.
PROJECT SCOPE
The Challenge
Solution
Objectives
Expected Impact
Encompassing a range of technological innovations, from wearable devices to telemedicine platforms, HealthTech has revolutionized the way care is delivered and received across the healthcare spectrum. This is particularly true in transitional care, which focuses on maintaining continuity as patients move between different stages and settings of care and relies upon a vast array of data and information gathered and exchanged between devices, systems, and word-of-mouth. Experimentation in transitional care is indispensable for developing specific technologies or innovative solutions that address the intricate and multifaceted nature of healthcare transitions. By subjecting these technologies to real-world scenarios, experimentation uncovers complexities, ethical considerations, interoperability challenges, and unforeseen barriers that controlled environments may not reveal. This process enables iterative refinement, customization, and validation of solutions to match diverse patient needs, ensure regulatory compliance, and address stakeholder concerns.
METHODOLOGY
The project is implemented through three interconnected phases that underpin its methodological approach
Phase 1 | Definition of Stakeholder Requirements and EVOLVE2CARE Experimentation Space Architecture
Phase 1 focuses on defining the specific requirements of the various stakeholders who are impacted by, or can impact, the process of validating HealthTech solutions in the transitional care industry. These conclusions will advance the development of the EVOLVE2CARE’s experimentation framework, utilizing AccelUP, which is a centralized marketplace platform where innovators (researchers, SMEs, startups, corporates) who utilize Living Lab services can find and connect with suitable labs.
Phase 2 | EVOLVE2CARE Experimentation space modules & services development
Phase 2 includes the actual development of the AccelUP marketplace modules and services (as defined in T1.4), which are necessary to set up the functionality of EVOLVE2CARE’s experimentation space and the matching of innovators and researchers in the transitional care sector to use Living Lab services from the AccelUP marketplace.
Phase 3 | Implementation of Experimentation Services and Space - AccelUP
Phase 3 includes the execution of the experimentation services, during which HealthTech innovations in the transitional care sector will be tested in Living Lab infrastructures identified in Phase 2. This phase includes the execution of each experiment for the Use Case identified, in realistic environments as well as the monitoring and evaluation of the experimentation process. The innovators who have been chosen and matched with a Living Lab will be given access to the agreed resources of the particular Living Lab. The matched labs will be offered payment vouchers by EVOLVE2CARE on behalf of the innovators to compensate for the experimentation services they will provide. An amount of 50.000 euros has been set aside in the budget to cover these costs, and EVOLVE2CARE anticipates that this funding will cover between 10-12 separate innovation experimentation instances of the predefined Use Cases. A mechanism for both parties i.e., a) Living Labs, and b) innovators, to provide feedback on the matching process will be established to refine the AccelUP platform process for future collaborations that will be achieved through a bidding process. Ongoing support and assistance to both parties during the collaboration will be offered by EVOLVE2CARE partners to address any challenges that arise and ensure a positive experience for everyone involved, while also informing and refining the design of the bidding process in the experimentation space of the AccelUP platform. Lessons learnt and best practices will be reported according to the standardised process defined in the Action Plan (T1.3) of AccelUP, along with the main research findings and reports on experiments, best practices, and explanations of the use case. Two knowledge sharing workshops will be held during the annual Open Living Lab Days, organized by ENOLL. In addition to showcasing the results of the project, these two workshops will gather stakeholders that have been engaged during the experimentation process and beyond and highlight the benefits of utilizing AccelUP.
PARTNERS
Our consortium is composed of five partners from five EU countries: Greece, Bulgaria, Belgium, Spain and Cyprus
The consortium partners count an already established community of over 480 Living Lab members in Europe and worldwide engaging with more than 500 innovators and researchers, 50 investors, and a massive reach of diverse stakeholders such as policy makers regulators and end-users, that can be a lever not only for the EVOLVE2CARE project but for the whole of EIC KIC communities.